Cross Country Healthcare Inc

Brodsky & Smith is investigating the boards of Personalis, Distribution Solutions Group, Cross Country Healthcare, Nuvalent, and Dana Incorporated for potential fiduciary duty breaches in connection with their proposed acquisitions. Personalis is being acquired by Tempus AI for $16.25 per share, representing a total enterprise value of $1.5 billion net of Tempus’ existing ownership. Distribution Solutions Group is being acquired by LKCM Headwater Investments for $35.00 per share in cash, with LKCM Headwater and its affiliates already owning approximately 79% of the company’s outstanding common stock. Cross Country Healthcare is being acquired by Knox Lane for $13.25 per share in an all-cash transaction valued at $437 million. Nuvalent is being acquired by GSK for $124.00 per share in cash in a deal valued at $10.6 billion. Dana is being acquired by Eaton in a transaction valued at approximately $5.1 billion, where Eaton shareholders will own at least 50.1% and Dana shareholders approximately 49.9% of the combined company at close, and Eaton will receive a cash distribution of approximately $1.1 billion. The investigations focus on whether the boards failed to conduct a fair process and whether the proposed transactions pay fair value to shareholders.

Monteverde & Associates PC, a class action firm, is investigating the proposed mergers of four companies. Open Lending Corporation is being sold to ANV Group Holdings Ltd. for $3.15 per share in cash. Huntsman Corporation is being sold to Olin Corporation, with shareholders expected to receive 0.5476 shares of Olin for each Huntsman share. Cross Country Healthcare, Inc. is being sold to KL Criss Cross Intermediate, LLC for $13.25 per share in cash, with a shareholder vote scheduled for July 16, 2026. Avanos Medical, Inc. is being sold to affiliates of American Industrial Partners for $25.00 per share in cash, with a shareholder vote scheduled for July 22, 2026.

Monteverde & Associates PC, a class action law firm, is investigating four proposed mergers. The firm is looking into Pacific Financial Corporation's merger with Banner Corporation, where Pacific Financial shareholders are expected to receive 0.2633 share of Banner common stock for each share held, with a shareholder vote scheduled for August 12, 2026. It is also investigating Nuvalent, Inc.'s sale to GSK plc for $124.00 per share in cash, Cross Country Healthcare, Inc.'s sale to KL Criss Cross Intermediate, LLC for $13.25 per share in cash with a shareholder vote set for July 16, 2026, and Bio Green Med Solution, Inc.'s merger with Future NRG Sdn. Bhd.